120 related articles for article (PubMed ID: 38187594)
1. Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.
Wittling MC; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Cole AC; Lesinski GB; Paulos CM
bioRxiv; 2023 Dec; ():. PubMed ID: 38187594
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning.
Nelson MH; Bowers JS; Bailey SR; Diven MA; Fugle CW; Kaiser AD; Wrzesinski C; Liu B; Restifo NP; Paulos CM
J Immunother Cancer; 2016; 4():6. PubMed ID: 26885368
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.
Bowers JS; Nelson MH; Kundimi S; Bailey SR; Huff LW; Schwartz KM; Cole DJ; Rubinstein MP; Paulos CM
Clin Cancer Res; 2015 Jun; 21(11):2546-57. PubMed ID: 25904754
[TBL] [Abstract][Full Text] [Related]
4. Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells.
Rigby SM; Rouse T; Field EH
Blood; 2003 Mar; 101(5):2024-32. PubMed ID: 12406908
[TBL] [Abstract][Full Text] [Related]
5. Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy.
Nissani A; Lev-Ari S; Meirson T; Jacoby E; Asher N; Ben-Betzalel G; Itzhaki O; Shapira-Frommer R; Schachter J; Markel G; Besser MJ
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33990415
[TBL] [Abstract][Full Text] [Related]
6. Potent tumor-specific protection ignited by adoptively transferred CD4+ T cells.
Liu Z; Noh HS; Chen J; Kim JH; Falo LD; You Z
J Immunol; 2008 Sep; 181(6):4363-70. PubMed ID: 18768895
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific Th17-polarized cells eradicate large established melanoma.
Muranski P; Boni A; Antony PA; Cassard L; Irvine KR; Kaiser A; Paulos CM; Palmer DC; Touloukian CE; Ptak K; Gattinoni L; Wrzesinski C; Hinrichs CS; Kerstann KW; Feigenbaum L; Chan CC; Restifo NP
Blood; 2008 Jul; 112(2):362-73. PubMed ID: 18354038
[TBL] [Abstract][Full Text] [Related]
8. T-Helper 22 Cell Type Responses to Nickel in Contact Allergic Subjects Are Associated with T-Helper 1, T-Helper 2, and T-Helper 17 Cell Cytokine Profile Responses and Patch Test Reactivity.
Masjedi K; Bruze M; Ahlborg N
Int Arch Allergy Immunol; 2023; 184(8):832-840. PubMed ID: 37105142
[TBL] [Abstract][Full Text] [Related]
9. Low-dose total body irradiation facilitates antitumoral Th1 immune responses.
Sonanini D; Griessinger CM; Schörg BF; Knopf P; Dittmann K; Röcken M; Pichler BJ; Kneilling M
Theranostics; 2021; 11(16):7700-7714. PubMed ID: 34335959
[TBL] [Abstract][Full Text] [Related]
10. Th17 and Th17-stimulated CD8⁺ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity.
Ankathatti Munegowda M; Deng Y; Mulligan SJ; Xiang J
Cancer Immunol Immunother; 2011 Oct; 60(10):1473-84. PubMed ID: 21660450
[TBL] [Abstract][Full Text] [Related]
11. BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control.
McGray AJR; Chiello JL; Tsuji T; Long M; Maraszek K; Gaulin N; Rosario SR; Hess SM; Abrams SI; Kozbor D; Odunsi K; Zsiros E
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37647218
[TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα
Kim SH; Cho E; Kim YI; Han C; Choi BK; Kwon BS
Nat Commun; 2021 Sep; 12(1):5314. PubMed ID: 34493727
[TBL] [Abstract][Full Text] [Related]
13. Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation.
Nishimoto S; Kotani H; Tsuruta S; Shimizu N; Ito M; Shichita T; Morita R; Takahashi H; Amagai M; Yoshimura A
J Immunol; 2013 Sep; 191(6):3065-72. PubMed ID: 23956432
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells.
Ding ZC; Habtetsion T; Cao Y; Li T; Liu C; Kuczma M; Chen T; Hao Z; Bryan L; Munn DH; Zhou G
Sci Rep; 2017 Sep; 7(1):12168. PubMed ID: 28939858
[TBL] [Abstract][Full Text] [Related]
15. Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
James RI; Warlick CA; Diers MD; Gunther R; McIvor RS
Blood; 2000 Aug; 96(4):1334-41. PubMed ID: 10942375
[TBL] [Abstract][Full Text] [Related]
16.
Hu X; Majchrzak K; Liu X; Wyatt MM; Spooner CJ; Moisan J; Zou W; Carter LL; Paulos CM
Cancer Res; 2018 Jul; 78(14):3888-3898. PubMed ID: 29769201
[TBL] [Abstract][Full Text] [Related]
17. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
[TBL] [Abstract][Full Text] [Related]
18. P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis.
Brown JB; Cheresh P; Zhang Z; Ryu H; Managlia E; Barrett TA
Inflamm Bowel Dis; 2012 Feb; 18(2):323-32. PubMed ID: 22009715
[TBL] [Abstract][Full Text] [Related]
19. Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome.
Wang L; Ma N; Okamoto S; Amaishi Y; Sato E; Seo N; Mineno J; Takesako K; Kato T; Shiku H
Oncoimmunology; 2016; 5(9):e1211218. PubMed ID: 27757303
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
